Table 3.
Definite Deterioration Group | ΔEcc | |||||
---|---|---|---|---|---|---|
| ||||||
Variables | OR | 95% CI | P | B | 95% CI | P |
Age, per y | 1.01 | 0.10, 1.03 | 0.38 | 0.005 | −0.02, 0.03 | 0.65 |
Male | 1.63 | 1.06, 2.52 | 0.03 | 0.70 | 0.32, 1.08 | <0.001 |
Body mass index, per kg/m2 | 1.02 | 0.97, 1.06 | 0.52 | 0.003 | −0.04, 0.04 | 0.90 |
Systolic blood pressure, per mmHg | 1.01 | 0.99, 1.02 | 0.12 | 0.002 | −0.008, 0.01 | 0.74 |
Diastolic blood pressure, per mmHg | 1.02 | 0.99, 1.04 | 0.18 | 0.02 | 0.005, 0.04 | 0.01 |
Hypertension | 1.30 | 0.84, 2.00 | 0.24 | 0.04 | −0.34, 0.42 | 0.84 |
Diabetes | 1.41 | 0.73, 2.72 | 0.30 | 0.31 | −0.27, 0.89 | 0.29 |
Current smoking | 2.11 | 1.52, 2.91 | <0.001 | 1.35 | 0.73, 1.97 | <0.001 |
Statin use | 1.32 | 0.77, 2.26 | 0.32 | 0.20 | −0.29, 0.69 | 0.42 |
Aspirin use | 1.42 | 0.86, 2.35 | 0.17 | 0.07 | −0.38, 0.51 | 0.77 |
Beta-blocker use | 1.52 | 0.79, 2.93 | 0.21 | 0.26 | −0.38, 0.89 | 0.43 |
ACE inhibitor use | 0.76 | 0.45, 1.80 | 0.76 | −0.25 | −0.81, 0.31 | 0.38 |
ARB use | 1.54 | 0.66, 3.62 | 0.32 | 0.21 | −0.60, 1.03 | 0.61 |
Urine albumin/creatinine, per mg/g | 1.00 | 0.99, 1.01 | 0.51 | −0.001 | −0.006, 0.003 | 0.57 |
LV mass index, per 1 g/m2 | 1.02 | 1.01, 1.04 | 0.002 | 0.03 | −0.87, −0.72 | <0.001 |
LV ejection fraction, per 1% | 1.00 | 0.95, 1.02 | 0.46 | −0.05 | −0.08, −0.03 | <0.001 |
Presence of coronary calcium | 1.32 | 0.86, 2.03 | 0.21 | 0.21 | −0.17, 0.58 | 0.28 |
CRP, per 1mg/dL | 1.07 | 1.04, 1.11 | <0.001 | 0.06 | 0.03, 0.097 | 0.001 |
See abbreviations in table 2